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 10 
Abstract 
 
In this paper, the effect of the gaseous environment on recrystallization of amorphous paracetamol was 
investigated. The experiments were conducted with a headspace gas consisting of dry air, dry carbon 
dioxide, dry nitrogen and humid air in four temperatures ranging from 5 ˚C below onset of Tg to 5 ˚C above 15 
onset of Tg. The recrystallization was monitored using Raman spectroscopy and subsequent multivariate 
analysis. In temperatures below onset of Tg, the presence of oxygen delayed the onset of recrystallization, 
with an increasing delay with lower temperature. When comparing samples exposed to dry headspace 
gases, the crystallization was fastest below onset of Tg when exposed to nitrogen. Being an inert gas, 
nitrogen did not seem to interfere with the molecules allowing them to freely find their inherent arrangement, 20 
whereas the presence of oxygen delayed the formation of stabile nuclei. Above onset of Tg, no differences in 
onset of crystallization was detected between dry gas atmospheres. Amorphous paracetamol crystallized to 
form II in all measurements and the samples did not reach full crystallinity within the duration of the 
experiments. The results show that the headspace gas has an effect on nucleation in the amorphous 
sample. 25 
 
 
Chemical compounds studied in this article: 
Paracetamol (PubChem CID 1983) 
 30 
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1 Introduction 
 35 
Solubility issues are an increasingly important challenge in drug development, as most new chemical entities 
suffer from insufficient water solubility, which is a severe limitation in medical applications.[1,2] Dissolution of 
the active ingredient is a prerequisite in successful drug therapy, since only dissolved drug molecules 
interact with their target receptors. Sufficient aqueous solubility enables therapeutically relevant 
concentrations of drug to be reached in the gastro-intestinal tract, which is a prerequisite for absorption, 40 
distribution and, in the end, the desired therapeutic effect. 
 
Poor aqueous solubility can be remedied through salt formation, using prodrugs, particle size reduction or 
rendering the material in an amorphous form.[3,4] Amorphous materials have superior kinetic solubility 
compared to their crystalline counterparts, since they have higher level of molecular disorder, free energy 45 
and molecular mobility. Nevertheless, they also tend to revert to their most stabile crystalline form. There has 
been considerable effort to investigate the nature of amorphous materials and how to maintain the 
amorphous form. However, the understanding of the crystallization process remains incomplete to date.[5,6] 
 
Recrystallization of amorphous material can occur in minutes, but at times the amorphous form can also be 50 
maintained for years. Typically, amorphous materials containing small molecules recrystallize faster than 
those containing big, flexible molecules.[7,8] In recent years, the importance of surface phenomena in the 
stability and recrystallization of amorphous drug substances has been established and highlighted.[9] 
Molecular mobility is significantly higher on the surface than in the bulk of amorphous glasses below the 
glass transition temperature.[9-13] This renders the surface molecules more susceptible to rearrange into 55 
crystal lattices than within the bulk. For example, in the case of felodipine, storage temperatures have to be 
at least 25 °C above Tg to achieve equal bulk and surface crystallization rates; below that temperature 
surface crystallization will dominate over bulk crystallization.[14] Since the onset of crystallization is surface-
driven, one could be inclined to assume that interaction between the molecules of the gas phase and the 
surface molecules will have an effect on the initiation and progress of recrystallization of amorphous 60 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
substances. Water molecules in the gaseous phase are known to have a great impact on the rate of 
crystallization of amorphous substances.[15] Water is readily absorbed into amorphous substances, where it 
acts an effective plasticizer lowering the glass transition temperature, subsequently enabling a significant 
increase in molecular mobility. As a consequence, the recrystallization rates increase correspondingly. 
 65 
Still, even though the interaction between molecules in the gaseous and solid phase is known to have an 
impact on the stability of the amorphous state in the case of water vapor, reports of the impact of other gases 
on amorphous pharmaceuticals are scarce. Qi et al. [16] and Perrin et al. [17] investigated the effect of 
nitrogen on the recrystallization of amorphous paracetamol. They found that at a specific temperature, 
paracetamol crystallized into metastable form III when exposed to a nitrogen atmosphere. One could, on the 70 
other hand, conclude that the atmosphere itself does not necessarily induce crystallization of form III, since 
form III is also formed in samples trapped under glass [18,19] or in a capillary [17] without having any contact 
to the atmosphere. Byrn et al. [20] reported that amorphous DL-Ala-DL-Met-dipeptide underwent oxidation to 
an extent of one magnitude more than its crystalline counterpart did. The reason for this may be the higher 
free volume and greater molecular mobility of amorphous substances compared to crystalline substances.  75 
When amorphous indomethacin was subjected to gaseous ammonia, the indomethacin reacted with the gas 
while still remaining amorphous.[21] Alpha-indomethacin also reacted with ammonia gas, whereas gamma-
indomethacin did not. The study showed that when the relevant functional group is exposed to the gaseous 
phase, a reaction between the gaseous phase and the solid may occur. In the case of amorphous samples, 
the more spacious packing and molecular mobility enable reactions between the gaseous phase and the 80 
amorphous surface. These examples suggest that headspace gas may have an effect on crystallization on 
amorphous pharmaceuticals to a further extent than currently acknowledged. 
 
In the present study, crystallization of amorphous paracetamol was investigated with a primary focus on 
onset of crystallization. Raman spectroscopy was used for both quantitative and qualitative analysis of the 85 
crystalline content in amorphous paracetamol samples prepared and stored in dry air, humid air, dry carbon 
dioxide and dry nitrogen atmospheres. The aim of the study was to investigate the effect of headspace on 
crystallization of amorphous paracetamol. Oxygen is known for being a reactive gas, that easily polarizes. As 
shown by Byrn et al. [20], gaseous oxygen is able to interfere with hydrogen bonding sites of amorphous 
substances, and therefore it was hypothesized that oxygen could be able to interact and form bonds with 90 
amorphous paracetamol, and consequently interfere with the crystallization tendency of amorphous 
paracetamol. Contrarily, nitrogen was expected to behave in accordance with its inert nature. This study 
shows that oxygen causes a delay in the onset of crystallization by bonding occasionally with paracetamol, 
which delays formation of stable nuclei. To our knowledge, this is the first time, when the effect of different 
headspace gases on the crystallization of an amorphous pharmaceutical was systematically investigated. 95 
Earlier, the effect of the gaseous phase on amorphous samples has been a minor part of some studies, but 
this is the first time multiple different gases are compared in the study with the primary aim of isolating the 
effects of the gaseous phase on amorphous samples. 
 
2 Materials and methods 100 
 
2.1 Sample preparation 
 
In the present study, crystalline paracetamol form I (Orion Pharma, Helsinki, Finland, Ph. Eur. quality) was 
used as model substance. Paracetamol has Tg of 24±2 °C depending on thermal history [16], and crystallizes 105 
rapidly even in cool temperatures [22]. In our study, onset of Tg was 22.3±0.1. Determination of Tg is 
described in more detail in chapters 2.2.1 and 3.1. 
 
The samples were prepared in a glove box with a set atmosphere consisting of dry air, nitrogen (N2), carbon 
dioxide (CO2) or humid air. As known, dry air consists of several gases, of which nitrogen (78.1%), oxygen 110 
(20.9%), argon (0.9%) and carbon dioxide (0.04%) are the most prominent ones. The raw material was kept 
in the selected atmosphere for a minimum of 10 min prior to melting. Cooling the sample and closing the 
sample holder (Fig. 1) were performed in a glove box with the selected atmosphere. 
 
Before preparing the amorphous samples, 10.00±0.08 mg of crystalline paracetamol (Form I) was placed in 115 
the glove box, which was subsequently closed. The selected gas was conducted into the glove box using a 
pressure of 1.6 bar. When the relative humidity in the glove box reached a stable equilibrium value, the 
sample was left to acclimatize for some ten minutes. In the measurement of amorphous substances, it must 
be kept in mind that they are hygroscopic. Consequently, if the measurement is conducted in an environment 
with deviates from that of dry gas and dry sample, the surface interaction between gas and solid is biased by 120 
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water interacting with the solid surface and gas interacting with water.[23] The equilibrium relative humidity of 
the gaseous phase in the present study was 4.4−4.7% for dry air, 1.2−1.5% for carbon dioxide, 0.0−0.1% for 
nitrogen and 21.1−22.2% for humid air. The sample was melted in situ in the sample holder on a hot plate at 
210 °C. The temperature was kept clearly above the melting point of paracetamol to ensure sufficient heat 
transfer through the sample holder. Because of the heat loss to the sample holder, the effective temperature 125 
reaching the sample was approximately 190 °C. The temperature was high enough to allow any residual 
water escape from the sample during melting. Consequently, the equilibrium humidity of the amorphous 
samples was determined by the relative humidity of the gaseous atmosphere. 
 
To ensure complete melting, the sample was kept on the hot plate for 3.5–4 minutes. The state of complete 130 
melting was determined through visual inspection. The sample was cooled down to 15.55±0.45 °C in a 
controlled manner using a cooled metallic block with a temperature of 13.15±0.25 °C. This was done to 
minimize the interaction of water with of high-energy regions that may be formed during quench cooling. 
Martínez et al. [24] reported that very fast cooling of paracetamol can lead to devitrification. The sample 
holder was sealed with the sample confined in the selected atmosphere. Degradation of sample was not 135 
detected after sample preparation, since there was no colour change and in the DSC results melting point of 
the sample was the same than in reference material. According to Gilpin and Zou [25], degradation would be 
under 0.2% in the selected conditions, which can be regarded as reasonably low. All steps of the sample 
preparation were completed with great attention focused on keeping the process identical between samples, 
since the thermal history of the sample has been shown to have a significant impact on the crystallization of 140 
amorphous paracetamol.[16] 
 
2.2 Solid-state analysis 
 
To study the solid-state state properties of the amorphous paracetamol, raw material and end products, 145 
various methods were employed as depicted in Figure 2 and further described in subsequent sections. 
 
2.2.1 Differential scanning calorimetry 
 
Samples of bulk paracetamol, freshly prepared amorphous samples and samples of end products were 150 
analysed using differential scanning calorimetry (DSC; DSC823e, Mettler-Toledo Inc., Switzerland). The 
sample sizes were 4.99-5.04 mg. Amorphous samples for differential scanning calorimetry (DSC) 
measurements were prepared as described above and detached from microscope slide using a scalpel 
immediately prior to analysis. Crystalline samples were measured after crystallization in temperatures of 18.3 
°C and 28.3 °C. All samples were held in -20 °C before initiating the heating cycle. The heating of the 155 
samples was conducted from -20 °C to 200 °C with a heating rate of 10 °C/min. 
 
2.2.2 Raman spectroscopy  
 
In the present study, a Raman spectrometer was used to allow measurement through the bottom of the 160 
sample holder and throughout the entire sample volume.  The measurement depth is described in more 
detail in Palomäki et al [26]. Monitoring the process of recrystallization of amorphous samples using Raman 
spectroscopy was initiated 10 minutes after completion of sample cooling in all experiments. The 
measurements were performed through the bottom of the sample holder to maximize measurement 
repeatability. Raman spectra were collected using a Raman RXN1-PhAT-785-D spectrometer (Kaiser, USA), 165 
PhAt system probe head (Kaiser optical systems, Inc, USA), a 400-mW laser source at 785 nm (Raman 
RXN1-PhAT-785-D, Kaiser aerospace & electronics company, USA) and spectral resolution of 0.3 cm-1. The 
used spectrometer differs from confocal Raman spectrometry by having a wider laser. Typically, the laser 
beam diameter is under 1mm, whereas in the PhAT system Raman diameter is 6 mm. Consequently, it 
saves the sample from heating. The wider laser area also makes the sensitivity to positioning and 170 
inhomogeneity of sample smaller. [27,28] Raman spectroscopy can be used to identify and quantify the 
amorphous-crystalline ratio in the sample [29,30], and has the ability to detect crystalline content down to 
approximately 1% [30]. Raman spectroscopy is non-invasive, non-destructive and rapid method, which is 
suitable for real-time monitoring of amorphous-crystalline transitions.[26,29] 
 175 
The measurements had an integration time of 0.5 seconds and one measurement was the result of three 
averaged scans. During the recrystallization experiments spectra were collected with 30-second intervals in 
four different temperatures: well below onset of Tg (17.2±0.3 °C), slightly below onset of Tg (21.7±0.2 °C), 
slightly above onset of Tg (23.9±0.4 °C) and well above onset of Tg (27.5±0.2 °C). 
 180 
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Reference samples of amorphous, form I and form II were made in triplicate as described by Kauffman et al. 
[31]. The reference samples were used to confirm the crystallization pathway of amorphous paracetamol. 
Reference sample containing polymorphic form III were not prepared, since the sample holder and 
temperature ranges in the present study do not enable formation of form III. Three measurements were 
conducted on each sample. One measurement was the average of three spectra acquired in a time period of 185 
30 seconds. The spectra were subjected to principal component analysis (PCA). Prior to the analysis, 
spectra were treated with Savitzky-Golay smoothening (window size 9, 3rd degree equation) and 1st 
derivative. The spectral area selected for PCA was 1586.7-1686.3 cm-1 due to the distinctive dual peak 
pattern known to be sensitive to paracetamol polymorphism.[18,31] The resulting PCA model was used to 
confirm the crystal form of the recrystallized paracetamol samples. 190 
 
Reference samples of amorphous and form II paracetamol for quantitative analysis were prepared by 
sandwiching a layer of molten paracetamol with a fixed height between a microscope slide and a cover slip. 
By combining and stacking samples, various levels of total crystallinity were achieved. The stacked samples 
were measured from opposite directions, and the spectra were averaged. The spectra were subjected to 195 
principal component analysis and PC1 was plotted against crystalline content. Linear correlation of PC1 
value and crystallinity of the sample enabled direct use of PC1 in the determination of crystallinity of the 
sample in the different timepoints. 
 
2.2.3 X-ray 200 
 
The end state crystallinity of samples exposed to dry air, humid air and nitrogen in the highest and lowest 
temperatures was determined using x-ray powder diffractometry (XRPD). The measurements were 
conducted using an x-ray diffractometer (Empyrean; Panalytical, Almelo, Netherlands) with a fixed 
divergence slit of 0.19 mm, general voltage of 45 kV and tube current of 40 mA. The step size was 0.01313˚ 205 
and time per step was 99.195 s. The measurement was performed over an angular range of 5 to 50˚. 
 
2.2.4 Microscopy 
 
Optical microscopy (Nikon Optishot; Tokyo, Japan) was used in visual inspection of the samples prepared in 210 
N2 atmosphere and measured in a temperature of 20.5-21.4 °C. 
 
3 Results and discussion 
 
3.1 Solid state analysis 215 
 
The solid state of the starting material, melted and cooled samples and end products were compared with 
data obtained of amorphous paracetamol and crystalline forms I and II (Fig. 3). The Raman spectrum of 
paracetamol has a distinctive double peak pattern in the Raman shift area of 1592-1634 cm-1.[18,31] In form 
I, the peaks are clearly separate. Conversion to form II causes the first peak to shift towards higher wave 220 
numbers whereas the second peak shifts towards lower wave numbers, resulting in the peaks being more 
pronouncedly overlapping. The Raman spectrum of the starting material showed distinct features of form I, 
whereas the recrystallized samples showed clear indications of form II. The sample holder caused clearly 
detectable background noise and the peaks were overall less distinguishable than those typically reported in 
the literature. Although the peaks are less intense, amorphous form and different polymorphs can be easily 225 
separated from each other. The amorphous samples showed mainly background caused by the sample 
holder. 
 
The Raman spectroscopy findings were confirmed using differential scanning calorimetry. The onset Tg of 
the amorphous sample was 22.3±0.1 °C and the sample started to recrystallize at 65.8±0.3 °C and the 230 
melting point was detected at 157.8±0.2 °C (Fig. 4). The melting point indicated that the amorphous sample 
had crystallized into form II, which corresponds to crystallization routes reported in previous studies using the 
same heating rate.22 XRPD results confirmed that at the end state, samples were crystallized to form II. 
 
The recrystallized amorphous samples showed signs of glass transition at the expected temperature range 235 
and form II as indicated in Raman spectroscopy measurements (Fig. 4). In the thermogram, a melting peak 
is detected at 169.0 °C, which corresponds to that of form I (168-172 °C) found in the literature.[22,32-34] No 
exothermic transitions indicating recrystallization prior to melting were detected in the thermogram. This is in 
line with findings by Kauffman et al. [31]. They used simultaneous Raman spectroscopy and DSC to 
measure aging of paracetamol form II. They discovered that paracetamol can convert from form II to form I 240 
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without showing evidence of an exothermic event in the thermogram. Furthermore, Di Martino et al. [33] 
reported that paracetamol form II produces a similar thermogram to form I, even though the forms were 
distinctively separate using XRPD. The present study provides further evidence that DSC is not a suitable 
analytical method to alone confirm presence of paracetamol form II. 
 245 
3.2 Recrystallization of amorphous paracetamol 
 
The Raman spectra obtained during monitoring of recrystallization show that the initial amorphous state is 
maintained for hours (Fig. 5). When crystallization occurred, the sample recrystallized to a fairly stable end 
state crystal content level within minutes, with the distinctive pattern of paracetamol form II gradually 250 
emerging in the Raman spectra. To ensure the crystallization pathway, a PCA model was constructed. The 
model had two components which combined explained 94.3% of the variation. The R2 and Q2 values were 
0.953 and 0.951, respectively (Fig. 6). The first component (83.4%) distinguished mainly crystalline 
paracetamol from amorphous, whereas the second component (11.9%) separated paracetamol form I from 
form II, although this division between information content in the components was not explicitly categorical. 255 
 
All samples crystallized from amorphous exclusively to form II, as expected based on literature 
findings.[18,31] The PCA model showed a distinct onset of crystallization, a rapid recrystallization and a 
clearly defined end state crystallinity. No signs of chemical degradation were seen in the Raman spectrum 
and no discoloration indicating thermal degradation was detected upon visual inspection of the samples. 260 
Furthermore, the gaseous atmospheres contained only marginal amounts of water. As no signs of oxidative 
or thermal degeneration were detected, and no evidence of water-induced plastization was seen in dry 
samples, one could be inclined to draw the conclusion that the observed phenomena were mainly governed 
by the physisorption of headspace gas molecules onto the amorphous surfaces. Andronis et al. [35] reported 
that limited amounts of humidity delayed the onset of crystallization and made the crystallization rate of 265 
amorphous indomethacin smaller. This phenomenon occurred, when the humidity was high enough to 
convert inclusive surface crystallization into bulk crystallization. However, in the present study, no sign of 
reduction of crystallization rate was seen when comparing crystallization of paracetamol samples in dry 
conditions at the lowest temperature. 
To investigate crystallization kinetics, linear parts of the crystallization curve were fit in the Avrami equation 270 
 = 1 − ((	τ)
)
, in which y is the amount of crystalline substance, k describes the rate of conversion, t is 
time, τ is the lag time before onset of crystallization and n describes the dimensionality of crystal 
growth.[36,37] In all dry samples Avrami constant n was about 1 indicating that crystallization happened 
exclusively in the surface (Table I). 
In almost all samples, the end state crystallinity was clearly below 100 % (Table I). Only two of the samples 275 
reached over 80% crystallinity. The incomplete crystallization is expected and can be below the glass 
transition temperature be attributed to the rapid nature of surface crystallization in comparison to bulk 
crystallization9, causes the crystallization rate to decrease significantly when surface crystallization is 
complete. In the super-cooled liquid state, amorphous paracetamol undergoes primary and secondary 
crystallization as described by Nikolakakis and Kachrimanis [38], with the secondary crystallization having a 280 
pronounced temperature dependency.  
 
The sample was fairly thick, which renders the bulk of the sample overrepresented in comparison to the 
surface, when comparing sample thicknesses presented in a number of studies found in the literature [11-
14,39-45]. The rapid crystallization, low end state crystallization and visual inspection of the samples confirm 285 
that the crystallization was strongly surface-bound. The variation in end state crystallinity between similar 
samples could be attributed to the sample attaining various shapes upon melting and cooling, which would 
alter the surface/bulk-ratio of the samples and also affect the temperature gradients within the sample during 
melting, cooling and storage. 
 290 
3.3 Effect of headspace gas on the recrystallization of amorphous paracetamol 
 
Stringent temperature and humidity control was needed to ensure that temperature and humidity effects 
were excluded, and rigorously executed sample preparation routines were applied to enable repeatable 
sample history. Having cleared these prerequisites, the gaseous environment needed to be created and 295 
stabilized. As explained in section 2.1., all of these features were achieved, and consequently one could 
expect that the effects of headspace gas is reflected in the results. As the molecular events in nucleation are 
very subtle in volume and the events as such were expected to be below the detection limit of relevant 
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analytical methods, direct evidence of interactions was not expected. Therefore, the crystal habit and 
recrystallization rate were used as indicators of events during the nucleation phase. 300 
 
In the present study, there were clear differences in onset of crystallization based on the composition of the 
headspace gas and temperature (Fig. 7). When storing the amorphous paracetamol well below Tg, the onset 
of crystallization was clearly delayed in the presence of dry air when compared to nitrogen, whereas no 
distinct difference between these was noticed clearly above the onset of Tg. This is in line with earlier 305 
findings. Zografi and Newman [46] reported that below Tg, non-relaxed amorphous samples absorb more 
water than relaxed samples, whereas above Tg similar behavior was not observed. Similarly, one could 
expect that any other component in the gaseous phase with a tendency to interact with the amorphous 
surface should show the same behavior. In the present study, this was clearly seen when comparing 
nitrogen and dry air above and below Tg. This can be attributed to the composition of the gaseous phase, 310 
since the samples were treated in the same way in all other aspects. 
 
As the interaction between gas and solid begins at the interphase, sorption is a relevant phenomenon to 
consider in the present study. The sorption of gases into amorphous solids can be divided into three 
separate steps: adsorption onto the surface, dissolution into the surface layer of the solid and diffusion into 315 
the matrix. The temperature of the system has a crucial role in all of these. Adsorption through physical 
interaction is known to be favored in low temperatures, which consequently means that as temperature 
increases, the amount of adsorption decreases correspondingly. The dissolution of gases is an exothermic 
process. In low temperatures, the solubility is thus higher than in high temperatures. As seen, the first two 
steps in sorption are both governed by temperature in the same way, i.e. in lower temperatures create the 320 
prerequisites for gas deposition from the gaseous phase into the solid phase. This partially explains the 
behavior observed in the present study as discussed below. 
 
Henry’s law postulates that the amount of dissolved gas in a liquid is dependent on the partial pressure of 
the headspace gas. An underlying assumption in Henry’s law sorption is that there is no interaction between 325 
the solute and the solvent, rendering diffusion of the gas molecules in the matrix purely Fickian.[47] In this 
case the diffusion would be governed by concentration gradient, distance, viscosity of the matrix, 
temperature and size of the diffusing molecule. When considering this framework, some conclusions can be 
made. Mateucci et al. [48] described the impact of the kinetic diameter of O2 (3.46 Å), N2 (3.64 Å) and CO2 
(3.3 Å) on diffusion in polymer matrices. They describe that the diffusion coefficients of gases in amorphous 330 
polymers are highly dependent on both kinetic diameter of the penetrant gas and the free volume of the 
amorphous system. Based on the kinetic diameters of the gases, one would expect carbon dioxide to diffuse 
into the bulk of the sample more readily than oxygen or nitrogen. The data of the present study, shown in 
Figure 7, however, does not indicate that the size of the diffusing penetrant would have any effect on the 
recrystallization of amorphous paracetamol. The free volume in the amorphous matrix, however, is greater 335 
than that in a super-cooled liquid [49], which may enable molecular interactions with gas to occur more 
readily below the glass transition temperature. Evidence of this is seen in Figure 7, that clearly shows that 
below Tg there are differences between effects of gases on amorphous paracetamol in the present study, 
whereas above Tg no clear difference can be seen. 
 340 
The viscosity of paracetamol melt at the melting point is around 101-102 Pa∙s [50] and as the temperature 
becomes lower the viscosity rapidly increases and reaches values of 1012-1014 Pa∙s in the glassy state [51]. 
As defined in the Stokes-Einstein equation, the diffusion coefficient is directly proportional to temperature 
and inversely proportional to the size of the gas molecule and the viscosity of the amorphous matrix. An 
increase in temperature would consequently have a dual effect on diffusion; the temperature increase itself 345 
would cause increased molecular motion and the increase in temperature would reduce viscosity, further 
promoting molecular mobility and consequently diffusion of gas from the surface to the bulk. In lower 
temperatures the opposite would hold, resulting in reduced diffusion from the surface to the bulk and 
consequently enabling a build-up of gas molecules on the surface of the glassy substance. This, combined 
with the fact that recrystallization of amorphous substances is highly surface-driven and the rigidity of the 350 
surface is a prerequisite for superior surface crystallization rate compared that of the bulk [9], further 
emphasizes that temperature is of key importance in the interactions at the solid/gas-interface of amorphous 
systems. This also supports the findings shown in Figure 7. 
 
When studying the temperature dependence of recrystallization of amorphous paracetamol, it is evident that 355 
the onset of recrystallization in the presence of humid air, N2 and CO2 is not temperature dependent, 
whereas the onset of crystallization is delayed in lower temperatures in the presence of dry air (Fig. 7 and 
Fig. 8). The effect of moisture on crystallization of amorphous samples is commonly known to be significant. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
When comparing the difference between dry air, humid air and N2 on the onset of crystallization below the 
glass transition temperature, one can see that the difference in onset of crystallization between dry air and 360 
N2 is comparable to that between dry air and humid air, which is commonly known to be of significant 
magnitude. This pronounces the importance of this study in showing that the effect of gaseous environment 
in crystallization is larger than previously known, and that the phenomenon itself deserves more attention in 
the scientific community. 
 365 
Taken together, the temperature dependency of onset of crystallization in the present study could be 
explained by the exothermic nature of adsorption and by the fact that as the temperature is lower, the 
solubility of gases into the amorphous matrix is lower. Furthermore, the viscosity of the amorphous glass is 
higher and as a consequence the surface is more rigid, which has been found to promote surface 
crystallization.[9] As the temperature exceeds the glass transition temperature, the sample becomes a 370 
super-cooled liquid, whereby surface crystallization is no longer dominant over bulk crystallization. This 
explains the fact that no difference in onset of crystallization was detected between headspace gases above 
the onset of glass transition temperature. In the temperatures of 17.2±0.3 °C, 21.7±0.2 °C and 23.9±0.4 °C, 
crystallization followed a typical sigmoidal curve. On the other hand, in the highest temperatures of 27.5±0.2 
°C and with dry atmospheres, crystallization occurred stepwise with sigmoidal steps followed by intermittent 375 
lag times. In the highest temperature, there was also great variation between samples. Instable 
crystallization kinetics of amorphous material above Tg has been supported by Yu [9]. The temperature 
dependence is clearly shown in Figure 7 and Figure 8, especially regarding crystallization in presence of dry 
air, and consequently the observed behaviour can be regarded as logical and expected. 
 380 
The rapid nature of crystallization of paracetamol in humid air as compared to dry air in the present study in, 
with a greater difference below glass transition than above, is an expected outcome. As commonly known, 
amorphous substances are hygroscopic, and water absorption plasticizes amorphous substances, which 
results in lower glass transition temperature and thus higher molecular mobility in isothermal conditions.[15] 
The crystallization rate of amorphous paracetamol has been shown to increase as relative humidity 385 
increases.[54,55] It has been reported that adsorbed water has an antiplasticizing effect at low levels of 
water uptake, which would postpone the onset of crystallization.[46] Furthermore, Novakovic et al. [56] found 
evidence of high-energy regions undergoing more extensive relaxation in elevated humidity compared to 
lower humidity, which resulted in less pronounced crystallization. However, the differences in onset of 
crystallization between dry air and N2 cannot be explained by differences in moisture content, when you 390 
consider the amount of water in the gas and the theoretical amount of collisions onto the sample surface 
(Table II). Furthermore, the moisture content in the carbon dioxide atmosphere lies between that of nitrogen 
and dry air, which is not reflected in onset of crystallization. This, in combination with the Avrami constant, 
indicates that the explanation to the difference in onset of crystallization between air and nitrogen cannot be 
explained by water interactions. 395 
 
It has previously been shown that gases may interact with hydrogen bond forming groups of amorphous 
substances [20,23,57], whereby the assumption of purely Fickian penetrant gas diffusion would become 
invalid. If there was any attractive interaction between the gas and the molecules in the glassy or super-
cooled substance, the diffusive transfer of gas molecules into the bulk could be delayed or disabled, leading 400 
to an accumulation of gas on and near the surface of the sample. In amorphous substances below Tg, the 
motion on the surface is considerably higher than that of the bulk, and it has been shown that 
recrystallization of amorphous substances is highly surface-driven.[9] Gunawan et al. [58] showed that there 
are hydrogen bonds between the amine group and phenolic hydroxyl and between the carbonyl oxygen and 
phenolic hydroxyl in the liquid and glassy state, and Tombari et al. [59] discuss that the molecules in glassy 405 
or liquid paracetamol are in motion due to constantly breaking and reforming hydrogen bonds between 
amine and hydroxyl groups of the paracetamol molecules. Furthermore, Gunawan et al. [58] showed that 
hydrogen bonding has an effect on the structural relaxation of the glass. Klopffer and Flaconnèche [47] 
showed with polymers, that as adsorbed gas molecules interact with the hydrogen bond forming groups in 
the amorphous matrix, the structural characteristics and state of motion of the molecules are disturbed. Trasi 410 
and Taylor [60] found that the bond between the phenolic hydroxyl and the carbonyl oxygen is stronger than 
the bond between the amine group and the phenolic hydroxyl. They studied hydrogen bonding in pure 
paracetamol and blends of polymers and paracetamol using FTIR, and found that introducing stronger 
hydrogen bond donors and acceptors to the system interfered with the hydrogen bonding network between 
paracetamol molecules, which reduced the amount of nuclei formed. Combined, these studies strongly 415 
suggest that amorphous paracetamol can interact with the gaseous environment and the interactions would 
have an effect on crystallization; the present study brings experimental observations that support this 
hypothesis. 
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In crystalline substances, it has been shown that different faces of the crystal interact with gases depending 420 
on which functional groups are exposed at the interface.[23] The interactions between amorphous solid 
surfaces and the gaseous phase is more complex than with crystalline substances, since the surface of 
amorphous solids is a dynamic interface that experiences variation in the form of random orientation of 
mobile molecules, constant migration towards more ordered states over time and changes over time in the 
form of relaxation. The molecules in the surface layer of amorphous paracetamol are randomly ordered, 425 
which presents various functional groups to the gaseous phase. Since physisorption can occur site 
specifically, one could assume that amine, phenolic hydroxyl and carbonyl oxygen of paracetamol with a 
tendency to hydrogen bonding, could interact with gaseous N2 and especially O2. The adsorption of gas 
molecules on the surface layer could interfere with the formation of nuclei of paracetamol form II, 
consequently delaying the onset of crystallization. As O2 has a more pronounced electronegativity than N2, 430 
one could expect that a headspace atmosphere containing O2 would more strongly interact with the 
hydrogen bonding sites of amorphous paracetamol and thus interfering with the hydrogen bonding network 
(Fig. 9) and formation of paracetamol form II nuclei. This hypothesis is supported by Manca et al. [58], who 
studied the interaction between gases and amorphous ice. They found that N2 and CO2 underwent site 
specific adsorption by hydrogen bonding with exposed hydroxyl groups on the surface of the amorphous 435 
substance. It cannot be excluded that similar site specific bonding can take place in amorphous paracetamol 
based on the results of the present study (Figure 7.), but obtaining direct evidence is highly challenging due 
to detection limit restrictions. 
 
Paracetamol is a compound known to readily form a glass when cooling the melt, but which recrystallizes 440 
rapidly upon heating.[60] The nucleation and growth temperature zones of paracetamol are also well 
separated, with a nucleation zone of 50-60 ˚C.[60] As all samples were cooled through the nucleation 
temperature zone and below the glass transition temperature in the present study, and kept below the crystal 
growth temperature zone, the effects of gas exposure are isolated on nucleation in the present study. As O2 
has a stronger tendency towards hydrogen bonding than N2, the decrease in crystallization onset in the 445 
present study may be caused by O2 forming hydrogen bonds on the sample surface, which decreases the 
amount of nuclei forming in the glass. As the temperature exceeds the glass transition temperature, bulk 
crystallization gains importance while gas adsorption becomes less pronounced, rendering the effect of gas 
exposure on the nucleation rate less prominent. Furthermore, effects on the structural relaxations of the 
amorphous glass cannot be excluded. No difference in crystallization rate was observed once the onset was 450 
detected (Table I), and all samples crystallized into form II as detected with DSC, Raman and XRPD, which 
further supports the gas having a primary effect on nucleation. 
 
The samples in the present study showed some variation in onset of crystallization within groups. In the 
amorphous samples that have been cooled from super-cooled liquid, one can find spatial and dynamic 455 
heterogeneity.[62,63] In other words, there are local regions of molecules relaxing at varying rate, which in 
the present study can be seen in the clear differences between onset times of crystallization within 
temperature and atmosphere categories (Table I). Kinetically these differences can be represented with 
potential energy mapping, which show distinct potential energy differences between different small areas in 
the sample.[64] Since the samples in the present study were not treated in a way that would cause nuclei to 460 
form, spatial and dynamic heterogeneity could have a significant impact on the length of the lag-time before 
onset of recrystallization since stable nuclei have to be formed before the crystallization can happen. 
Heterogeneous nucleation may occur, when foreign surfaces interacts with the amorphous material.[65,66] 
In the present study, the onset of crystallization occurred at the edge of the sample where the super-cooled 
liquid phase, solid glass phase and gaseous phase met (Fig. 10a). From the edge of the sample the 465 
crystallization progressed along the sample surface towards the centre of the sample (Fig. 10b). Surface 
curvature, pronounced molecular mobility on the surface and contact with the foreign glass surface could in 
combination generate high energy sites at the contact point between the phases, which could facilitate the 
onset of crystallization. A broad standard deviation in crystallization onset is thus an expected finding, and a 
fact that brings further challenge into this complicated experimental setup. 470 
 
To summarize, it is known that physisorption is facilitated in low temperatures and may occur through 
hydrogen bonding in active sites. The adsorption and dissolution of gases into the matrix increase whereas 
viscosity of amorphous samples becomes higher with decreasing temperature. Combined with the tendency 
towards surface crystallization, it can be concluded that the headspace gas affects the onset of 475 
recrystallization of paracetamol below Tg. In temperatures above Tg the opposite occurs and the differences 
caused by variation in headspace gas are canceled. In addition, in temperatures above Tg bulk crystallization 
gains significance while surface crystallization becomes less prominent. 
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Conclusions 480 
 
The headspace gas seems to have a more significant role in the stability of amorphous pharmaceuticals than 
previously reported. The present study showed that in amorphous paracetamol samples, exposure to dry air 
delayed the onset of crystallization in comparison to samples exposed to pure nitrogen when the 
temperature was kept below Tg.  Above Tg no difference between dry air and nitrogen was detected. The 485 
results imply that oxygen, being a reactive gas, was adsorbed onto the surface of the amorphous glass 
where it interfered with the hydrogen bonding between paracetamol molecules. This may have prevented 
nucleation and subsequently delayed the onset of crystallization. Nitrogen, being an inert gas, does not 
interact with the sample surface, and consequently the nucleation and onset of crystallization occurred 
without molecular interaction between the gaseous and solid phases, leaving the sample to behave 490 
according to its inherent physical instability. Since atmospheric gases may have an effect on the physical 
stability of amorphous pharmaceutics, more studies are needed in this area to fully clarify the nature of 
interaction between the headspace gas and amorphous pharmaceuticals. The present study confirms that 
this previously neglected topic deserves further attention in the scientific community. 
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Figure 1. Schematic representation of the sample holder. The sample holder enables maintaining an isolated 
gaseous atmosphere during storage. The Raman measurements were performed through the glass bottom 710 
of the sample holder. 
 
Figure 2. Flow diagram of the processing and solid-state analysis of amorphous paracetamol. 
 
Figure 3. Typical Raman spectra of a) Form I, b) amorphous and c) Form II paracetamol obtained in the 715 
present study.  
 
Figure 4. Typical DSC thermograms of a) form I reference sample (dark grey, dashed), b) amorphous 
paracetamol (black) and c) crystallized form II sample (light grey). 
 720 
Figure 5. Typical Raman spectra of amoprhous paracetamol recrystallizing in the presence of dry air 
(T=21.8-21.9 °C) without pretreatments. 
 
Figure 6. PCA models of crystallization of representative samples of amorphous paracetamol at temperature 
of 21.7±0.2 °C in a) dry air atmosphere, b) dry carbon dioxide atmosphere, c) dry nitrogen atmosphere and 725 
d) humid air atmosphere. Recrystallizing samples are shown with small black circles, amorphous reference 
samples with red unfilled circles, form I reference samples with red unfilled triangles and form II reference 
samples with red unfilled squares. Data points are shown with 1-minute intervals from 0 to 1200 minutes to 
alleviate interpretation. 
 730 
Figure 7. Average onset of crystallization of paracetamol in different temperatures and headspace 
atmospheres. 
 
Figure 8. Average onset of crystallization of paracetamol in dry air atmosphere. 
 735 
Figure 9. Hydrogen bonding network of paracetamol form II. [61] 
 
Figure 10. Microscope image of the progress of recrystallization of amorphous paracetamol. 
 
Table I. Crystallization of paracetamol in different temperatures and atmospheres. 740 
 
Table II. Amount of water in various gas mixtures and collision number of water molecules. Calculations 
assume temperature of 20°C and normal atmospheric pressure. 
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Table I. Crystallization of paracetamol in different temperatures and atmospheres. 
Temperature 
(°C) 
Atmosphere On set of 
crystallization 
(min) 
Crystallization 
time (min) 
End state 
crystallinity 
(%) 
Avrami 
constant n 
17.1-17.3 Air 1457.0 50.5 41.9 0.95 
16.9-17.1 Air 1502.5 94.0 59.3 1.00 
17.0-17.2 Air 1161.5 75.0 64.9 1.06 
17.0-17.2 Carbon dioxide 238.0 50.5 31.6 0.98 
17.0-17.2 Carbon dioxide 707.0 29.0 46.3 1.17 
17.0-17.2 Carbon dioxide 807.5 75.5 53.4 0.97 
17.1-17.4 Nitrogen 294.0 25.0 28.9 0.67 
17.1-17.4 Nitrogen 574.5 74.0 42.5 0.83 
17.1-17.4 Nitrogen 664.0 78.0 19.9 0.54 
17.3-17.4 Humid air 220.5 134.5 34.3 1.01 
17.3-17.4 Humid air 213.0 66.0 39.6 1.45 
17.0-17.2 Humid air 87.5 157.0 37.1 1.43 
21.9 Air 1210.0 27.0 82.2 1.71 
21.8-21-9 Air 801.0 35.0 85.8 1.74 
21.8-21-9 Air 1000.0 21.5 22.0 2.08 
21.8-21-9 Carbon dioxide 1158.5 49.0 42.6 1.15 
21.8-21-9 Carbon dioxide 639.5 21.0 62.2 0.90 
21.7-21.8 Carbon dioxide 675.5 17.0 51.9 0.87 
21.5-21.7 Nitrogen 298.0 39.5 50.0 0.65 
21.7-21.8 Nitrogen 521.0 40.5 28.7 0.84 
21.7-21.8 Nitrogen 765.5 98.0 70.6 1.55 
21.6-21.8 Humid air 284.0 132.0 50.6 2.18 
21.5-21.8 Humid air 198. 108.0 33.5 1.21 
21.5-21.7 Humid air 203.5 98.0 34.6 1.35 
23.7-23.9 Air 954.0 76.5 58.4 1.48 
23.5-24.1 Air 781.5 53.0 68.1 1.07 
23.7-24.1 Air 759.0 41.0 61.7 0.89 
23.6-24.2 Carbon dioxide 518.0 58.0 60.0 0.91 
23.7-24.0 Carbon dioxide 598.5 19.0 37.2 1.17 
23.6-23.9 Carbon dioxide 435.0 12.5 50.4 0.91 
23.8-24.0 Nitrogen 445.5 38.5 39.8 1.30 
23.6-24.3 Nitrogen 445.5 33.5 51.4 0.85 
23.6-24.2 Nitrogen 278.5 98.0 71.6 1.96 
24.1-24.2 Humid air 332.5 89.0 34.4 0.97 
24.0-243 Humid air 77.0 87.0 18.4 1.13 
23.8-24.0 Humid air 219.5 98.0 36.3 0.99 
27.3-27.4 Air* 161.5 64.5 29.5 1.15 
27.5-27.7 Air 630.0 20.0 50.0 1.08 
27.3-27.5 Air* 294.0 163.5 29.5 1.62 
27.5-27.7 Carbon dioxide* 448.0 668.5 44.3 0.88 
27.4-27.5 Carbon dioxide* 554.5 290.0 61.7 1.02/1.37 
27.3-27.6 Carbon dioxide* 762.5 408.0 55.9 0.93/1.18 
27.4-27.6 Nitrogen* 191.0 169.0 26.9 0.78 
27.4-27.7 Nitrogen* 318.0 172.5 16.7 1.21 
27.4-27.6 Nitrogen* 385.0 295.5 33.2 1.33 
27.3-27.6 Humid air 225.0 193.0 41.6 1.15 
27.5-27.7 Humid air 138.0 104.5 36.9 1.49 
27.4-27.7 Humid air 68.5 327.5 34.1 1.33 
 
*non-sigmoidal crystallization profile (crystallization slows down and becomes faster multiple times) 
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Table II. Amount of water in various gas mixtures and collision number of water molecules. Calculations 
assume temperature of 20°C and normal atmospheric pressure. 
Atmosphere RH% H2O (g/m3) H2O (m/m-%) in the 
atmosphere 
Theoretical amount of 
collisions between gaseous 
H2O molecules and the 
sample surface (n/Å2/s)* 
Air 4.4-4.7 0.76-0.81 0.06 4200-4400 
CO2 1.2-1.5 0.21-0.26 0.02 1100-1400 
N2 ≤0.1 ≤0.2 0.0 ≤ 100 
Humid air 21.2-22.2 3.67-3.85 0.29-0.30 20000-21000 
 
*collision frequency [52,53] 
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